Once the wunderkind of the Boston biotech venture capital community, Joshua is upended by a series of events... violent hostility at work, estrangement from his only remaining family, and the sudden death of a loved one from a rare, aggressive cancer that's plagued small farming communities across the American heartland.

As a Dutch pharmaceutical giant races to roll out a potential cure, Joshua sets his sights on a deeper problem... the source.